Costs of patients hospitalized for multidrug-resistant tuberculosis.

Srijana Rajbhandary, Suzanne M. Marks, Naomi Bock

PubMed · 2004 · 87 citations · 6 references

Full text

Open access

Abstract

The societal costs of MDR-TB varied, mostly because of length of therapy (including in-patient), and deaths during treatment.

References

6